AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33064415 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 3
Study 33714257 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven ferroptosis-related lncRNAs signature (LINC01503, AC004687.1, AC010973.2, AP001189.3, ARRDC1-AS1, OIP5-AS1, and NCK1-DT)
Number of subjects: 905
Study 33714257 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven ferroptosis-related lncRNAs signature
Number of subjects: 905
Study 32084251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3220
Study 32084251 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 3220
Study 32084251 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3220
Study 33345583 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders for Homeless Women (UPHW)
Number of subjects: 81
Study 33345583 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 81
Study 34537385 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg/day)
Number of subjects: 97
Study 34537385 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide (5 mg/day)
Number of subjects: 97
Study 33337694 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training (varied emphasis: Es = 25/75%, SE = 50/50%, Se = 75/25%)
Number of subjects: 78
Study 33337694 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training
Number of subjects: 78
Study 33337694 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 78
Study 32976626 — intervention group
Group type: EXPERIMENTAL
Intervention: One standard drink/day increase in alcohol consumption (observational analysis)
Number of subjects: 0
Study 32976626 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted one standard drink/day increase in alcohol consumption (Mendelian randomization analysis)
Number of subjects: 0
Study 33390020 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinus Tarsi Approach (STA)
Number of subjects: 64
Study 33390020 — intervention group
Group type: COMPARATOR
Intervention: Extensile Lateral Approach (ELA)
Number of subjects: 64
Study 33512807 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk oligosaccharides (HMOs) - 5g daily dose of 2'‐fucosyllactose and lacto‐N‐neotetraose in a 4:1 mix
Number of subjects: 317
Study 34773474 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib + momelotinib (200 mg QD)
Number of subjects: 11
Study 34773474 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib + momelotinib (100 mg BID)
Number of subjects: 11
Study 34773474 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib + momelotinib (various doses)
Number of subjects: 11
Study 34773474 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib
Number of subjects: 11
Study 33592831 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 171
Study 33592831 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study 35142931 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 64
Study 35142931 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 64
Study 33724062 — intervention group
Group type: EXPERIMENTAL
Intervention: Second MRI screening round
Number of subjects: 3436
Study 33724062 — intervention group
Group type: COMPARATOR
Intervention: First MRI screening round
Number of subjects: 3436
Study 33835873 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic radical prostatectomy (RALP)
Number of subjects: 65
Study 33835873 — intervention group
Group type: COMPARATOR
Intervention: Three-dimensional laparoscopic radical prostatectomy (3D LRP)
Number of subjects: 65
Study 32439297 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon
Number of subjects: 64
Study 32439297 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stent
Number of subjects: 64
Study 32439297 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon or Everolimus-eluting stent
Number of subjects: 64
Study 33729724 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 703
Study 33729724 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 703
Study 32030694 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular and axillary nerve block (group SSAXB, n=23)
Number of subjects: 46
Study 32030694 — intervention group
Group type: COMPARATOR
Intervention: Subacromial local infiltration (group C, n=23)
Number of subjects: 46
Study 34088249 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health interventions focusing on depressive symptoms and behavior change skills (e.g., self-efficacy)
Number of subjects: 424
Study 33030228 — intervention group
Group type: EXPERIMENTAL
Intervention: rhFGF‐2 + DBBM (test)
Number of subjects: 38
Study 33030228 — intervention group
Group type: COMPARATOR
Intervention: rhFGF‐2 (control)
Number of subjects: 38
Study 35655058 — intervention group
Group type: EXPERIMENTAL
Intervention: myCompass online CBT program for 6 weeks
Number of subjects: 50
Study 35655058 — intervention group
Group type: COMPARATOR
Intervention: paper-based health education program
Number of subjects: 50
Study 33486062 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS Mobility score
Number of subjects: 57
Study 33486062 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS Pain Interference score
Number of subjects: 57
Study 33486062 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMIS Upper Extremity score
Number of subjects: 57
Study 33486062 — intervention group
Group type: COMPARATOR
Intervention: Legacy metrics (KJOC, QuickDASH, Liverpool-PAQ)
Number of subjects: 57
Study 33486062 — intervention group
Group type: COMPARATOR
Intervention: KJOC score
Number of subjects: 57
Study 33389504 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable video media (PVM) consent
Number of subjects: 60
Study 33389504 — intervention group
Group type: COMPARATOR
Intervention: Standard verbal consent (SVC)
Number of subjects: 60
Study 32927688 — intervention group
Group type: EXPERIMENTAL
Intervention: High temperature (HT)
Number of subjects: 0
Study 32927688 — intervention group
Group type: COMPARATOR
Intervention: Low temperature (LT)
Number of subjects: 0
Study 32927688 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 days post-anthesis (4 dpa) stage
Number of subjects: 0
Study 32927688 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentially expressed genes (DEGs)
Number of subjects: 0
Study 32927688 — intervention group
Group type: EXPERIMENTAL
Intervention: Candidate genes related to fuzz initiation
Number of subjects: 0
Study 32927688 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional annotation
Number of subjects: 0
Study 32927688 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression trends
Number of subjects: 0
Study 36018275 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP‐PMH (video feedback intervention for positive parenting adapted for perinatal mental health)
Number of subjects: 34
Study 36018275 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study 33217131 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-guided (RG) placement of percutaneous pedicle screw instrumentation
Number of subjects: 0
Study 33217131 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic-guided (FG) placement of percutaneous pedicle screw instrumentation
Number of subjects: 0
Study 37441660 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glibenclamide
Number of subjects: 84
Study 37441660 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin
Number of subjects: 84
Study 34454468 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental active presence technique (PAP)
Number of subjects: 150
Study 34454468 — intervention group
Group type: COMPARATOR
Intervention: Parental passive presence technique (PPP)
Number of subjects: 150
Study 36374913 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD-701
Number of subjects: 312
Study 36374913 — intervention group
Group type: COMPARATOR
Intervention: Reference ranibizumab
Number of subjects: 312
Study 35299690 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed teaching mode
Number of subjects: 80
Study 35299690 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching mode
Number of subjects: 80
Study 35132556 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone co-dispensing
Number of subjects: 768
Study 35132556 — intervention group
Group type: COMPARATOR
Intervention: Usual care pharmacies
Number of subjects: 768
Study 35672861 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative inspiratory muscle training using Power®Breathe KHP2, 30 breaths twice a day for at least 2 weeks before surgery (can be extended up to 6 weeks).
Number of subjects: 0
Study 35672861 — intervention group
Group type: COMPARATOR
Intervention: No preoperative inspiratory muscle training (control group).
Number of subjects: 0
Study 35993772 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cryotherapy
Number of subjects: 22
Study 35993772 — intervention group
Group type: COMPARATOR
Intervention: In-hospital liquid nitrogen therapy
Number of subjects: 22
Study 33662589 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 0
Study 33662589 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact umbilical cord milking (I-UCM)
Number of subjects: 0
Study 33662589 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut umbilical cord milking (C-UCM)
Number of subjects: 0
Study 33662589 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35235197 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback (BOF) alone
Number of subjects: 88
Study 35235197 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback + fiber laxative (psyllium)
Number of subjects: 88
Study 35235197 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback + osmotic laxative (polyethylene glycol; PEG)
Number of subjects: 88
Study 35235197 — intervention group
Group type: COMPARATOR
Intervention: All groups (including controls)
Number of subjects: 88
Study 32179564 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioural therapy (iCBT) for Depression, available only in Finnish.
Number of subjects: 0
Study 36205538 — intervention group
Group type: EXPERIMENTAL
Intervention: COBRA-light (prednisolone 30 mg/day tapered to 7.5 mg/day, MTX increasing to 25 mg/week)
Number of subjects: 190
Study 36205538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensification (prednisolone 60 mg/day tapered to 7.5 mg/day, addition of SSZ (2 g/day) and HCQ (400 mg/day))
Number of subjects: 190
Study 36205538 — intervention group
Group type: COMPARATOR
Intervention: Continuation (no intensification)
Number of subjects: 190
Study 36205538 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX monotherapy increasing to 25 mg/week
Number of subjects: 190
Study 36205538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensification (prednisolone 30 mg/day tapered to 7.5 mg/day)
Number of subjects: 190
Study 32001164 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiologists' prediction of upstaging to invasive disease
Number of subjects: 150
Study 35959775 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu injection (SFI)
Number of subjects: 40
Study 35959775 — intervention group
Group type: COMPARATOR
Intervention: Placebo (glucose injection)
Number of subjects: 40
Study 34060934 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 112
Study 34060934 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 112
Study 34060934 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 112
Study 34060934 — intervention group
Group type: EXPERIMENTAL
Intervention: Active MT
Number of subjects: 112
Study 32762916 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 0
Study 32762916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35259525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 85
Study 35259525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 33915217 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) - 25 Gy in 10 fractions
Number of subjects: 84
Study 33915217 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 84
Study 33624254 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 0
Study 33624254 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 0
Study 33624254 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 0
Study 33624254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34231934 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover interventions
Number of subjects: 434
Study 34231934 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trial
Number of subjects: 434
Study 34231934 — intervention group
Group type: EXPERIMENTAL
Intervention: Before-after-control-impact
Number of subjects: 434
Study 34231934 — intervention group
Group type: COMPARATOR
Intervention: Before-after studies
Number of subjects: 434
Study 34231934 — intervention group
Group type: COMPARATOR
Intervention: Control-impact studies
Number of subjects: 434
Study 34231934 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover designs
Number of subjects: 434
Study 34376213 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 16676
Study 34376213 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-light intensity physical activity (HLPA)
Number of subjects: 16676
Study 34376213 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity guidelines (mean, 36 min/day MVPA, 79 min/day HLPA, 227 min/day LLPA, 549 min/day SB)
Number of subjects: 16676
Study 34376213 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-light intensity activity (HLPA) and lower-light intensity activity (LLPA)
Number of subjects: 16676
Study 34376213 — intervention group
Group type: COMPARATOR
Intervention: Sedentary behavior (SB)
Number of subjects: 16676
Study 32029415 — intervention group
Group type: EXPERIMENTAL
Intervention: Video lecture and high fidelity simulation
Number of subjects: 52
Study 32029415 — intervention group
Group type: COMPARATOR
Intervention: Video lecture
Number of subjects: 52
Study 35543329 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive 3D software package
Number of subjects: 50
Study 35543329 — intervention group
Group type: COMPARATOR
Intervention: Standard PowerPoint presentation
Number of subjects: 50
Study 33606044 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-clamp robotic partial nephrectomy (RPN)
Number of subjects: 1359
Study 33606044 — intervention group
Group type: COMPARATOR
Intervention: On-clamp robotic partial nephrectomy (RPN)
Number of subjects: 1359
Study 33606044 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-clamp RPN
Number of subjects: 1359
Study 33606044 — intervention group
Group type: COMPARATOR
Intervention: On-clamp RPN
Number of subjects: 1359
Study 36047014 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial dry needling (DN)
Number of subjects: 30
Study 36047014 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling (C)
Number of subjects: 30
Study 33503313 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P17
Number of subjects: 312
Study 33503313 — intervention group
Group type: COMPARATOR
Intervention: US-adalimumab
Number of subjects: 312
Study 33503313 — intervention group
Group type: COMPARATOR
Intervention: EU-adalimumab
Number of subjects: 312
Study 32448810 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to donate organs after death
Number of subjects: 1000
Study 32448810 — intervention group
Group type: EXPERIMENTAL
Intervention: Registration with the Centralised Organ Donation Register (CODR)
Number of subjects: 1000
Study 32448810 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for not registering with CODR
Number of subjects: 1000
Study 32448810 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of registration methods
Number of subjects: 1000
Study 32448810 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media effectiveness
Number of subjects: 1000
Study 36170281 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal-flow: 0.25 l.min-1 via endotracheal tube
Number of subjects: 125
Study 36170281 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow: 2 l.min-1 + continuous jaw thrust
Number of subjects: 125
Study 36170281 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-flow: 10 l.min-1 + continuous jaw thrust
Number of subjects: 125
Study 36170281 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow: 70 l.min-1 + continuous jaw thrust
Number of subjects: 125
Study 36170281 — intervention group
Group type: COMPARATOR
Intervention: Control: 70 l.min-1 + continuous video-laryngoscopy
Number of subjects: 125
Study 34180292 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (83 patients) had a DEXA scan and FRAX calculated.
Number of subjects: 180
Study 34180292 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (DEXA and FRAX)
Number of subjects: 180
Study 34180292 — intervention group
Group type: COMPARATOR
Intervention: Control group (100 patients)
Number of subjects: 180
Study 34180292 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (DEXA)
Number of subjects: 180
Study 35704597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg, once daily)
Number of subjects: 122
Study 35704597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 35151021 — intervention group
Group type: EXPERIMENTAL
Intervention: Common humanity-enhanced exposure (n = 32)
Number of subjects: 63
Study 35151021 — intervention group
Group type: COMPARATOR
Intervention: Exposure alone (n = 31)
Number of subjects: 63
Study 32702759 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based education (CBE)
Number of subjects: 497
Study 32702759 — intervention group
Group type: COMPARATOR
Intervention: Nurse counselling
Number of subjects: 497
Study 616858603 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention along with conventional drug therapy
Number of subjects: 115
Study 616858603 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient care and conventional drug therapy
Number of subjects: 115
Study 34356965 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (muscle conditioning)
Number of subjects: 40
Study 34356965 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical activity)
Number of subjects: 40
Study 35717855 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based Compassion-Focused Therapy (CFT)
Number of subjects: 82
Study 35717855 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 82
Study 32398112 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sijunzi decoction (SJZD)
Number of subjects: 10
Study 32398112 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 10
Study 34843329 — intervention group
Group type: EXPERIMENTAL
Intervention: Benefit-finding therapeutic (BFT) intervention
Number of subjects: 129
Study 34843329 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (control)
Number of subjects: 129
Study 32959585 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint selection of meridian diagnosis
Number of subjects: 70
Study 32959585 — intervention group
Group type: COMPARATOR
Intervention: Regular acupoint selection
Number of subjects: 70
Study 34961383 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigma-reducing video intervention
Number of subjects: 277
Study 34961383 — intervention group
Group type: EXPERIMENTAL
Intervention: Utility-enhancing video intervention
Number of subjects: 277
Study 34961383 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 277
Study 33826497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 2725
Study 33826497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 2725
Study 33826497 — intervention group
Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study 36231747 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (L. salivarius)
Number of subjects: 140
Study 36231747 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual treatment)
Number of subjects: 140
Study 34252340 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsiate supplementation (CTRLcap)
Number of subjects: 13
Study 34252340 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CTRLpla)
Number of subjects: 13
Study 34252340 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsiate supplementation with exercise (EXcap)
Number of subjects: 13
Study 34252340 — intervention group
Group type: COMPARATOR
Intervention: Placebo with exercise (EXpla)
Number of subjects: 13
Study 34175315 — intervention group
Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 60
Study 34175315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32926504 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 24471
Study 32926504 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dimensional propensity score (hd-PS) modifications
Number of subjects: 24471
Study 35918695 — intervention group
Group type: EXPERIMENTAL
Intervention: MFGM-enriched formula (MF)
Number of subjects: 375
Study 35918695 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 375
Study 35918695 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed reference (BFR)
Number of subjects: 375
Study 33207015 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ tree SLIT-tablet (containing birch extract)
Number of subjects: 397
Study 33207015 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 397